An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.

Guests

  • Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
  • Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
  • William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
  • Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Wayne Pacelle: “The Humane Economy”

Thursday, Apr 28 2016This has been a significant year for the animal rights movement. Sea World vowed to stop breeding orcas. And Walmart pledged to sell only cage-free eggs. The head of the Humane Society on how consumer pressure and innovation are driving animal protection.

Readers’ Review: “My Name Is Lucy Barton” By Elizabeth Strout

Wednesday, Apr 27 2016For our April Readers’ Review: the latest novel by the author of "The Burgess Boys" and the Pulitzer-Prize winning "Olive Kitteridge." It's the story of a woman who escapes a troubled childhood and becomes a writer. A surprise visit from her mother opens a portal to her past and awakens a subtle tenderness between them. Join Diane and her guests for a discussion of "My Name Is Lucy Barton."